NCT02188589View on ClinicalTrials.gov

Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2017

Conditions
Nasal Valve Collapse
Interventions
DEVICE

INEX nasal implant

Treatment group may receive unilateral or bilateral INEX nasal implants (maximum of 4, 2 per side)

Trial Locations (1)

81377

Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde am Klinikum der LMU, Munich

All Listed Sponsors
lead

Spirox, Inc.

INDUSTRY

NCT02188589 - Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse | Biotech Hunter | Biotech Hunter